Current status: 977 hESC lines, 6342 hiPSC lines, and 153 clinical studies, and 2335 certificates
Monthly statistic from Aug 1, 2024
Posted on August 1, 2024
total lines | 7319 |
hESC lines | 977 |
hiPSC lines | 6342 |
derivation countries | 50 |
projects | 304 |
providers | 917 |
clinical studies | 153 |
subclones | 2956 |
certificates | 2335 |
cell line certificates | 2190 |
project certificates | 145 |